Nanogen, Inc., developer of molecular diagnostic products for the gene-based testing market, and SYN X Pharma, Inc, a point-of-care diagnostics company, announced today the signing of a definitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results